Two Biosimilars Approved in Europe for Autoimmune Disorders Two Biosimilars Approved in Europe for Autoimmune Disorders
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn ' s disease.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pharmacist News Alert Source Type: news
More News: Allergy | Allergy & Immunology | Arthritis | Autoimmune Disease | COVID-19 | Crohn's Disease | Inflammatory Bowel Disease | Psoriasis | Rheumatology